Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

January 19, 2016

Primary Completion Date

August 4, 2017

Study Completion Date

August 4, 2017

Conditions
Atopic Dermatitis
Interventions
DRUG

Tradipitant

DRUG

Placebo

Trial Locations (28)

10022

Vanda Investigational Site, New York

10075

Vanda Investigational Site, New York

19104

Vanda Investigational Site, Philadelphia

27104

Vanda Investigational Site, Winston-Salem

27262

Vanda Investigational Site, High Point

28405

Vanda Investigational Site, Wilmington

29407

Vanda Investigational Site, Charleston

31904

Vanda Investigational Site, Columbus

32174

Vanda Investigational Site, Ormond Beach

33126

Vanda Investigational Site, Miami

33136

Vanda Investigational Site, Miami

46168

Vanda Investigational Site, Plainfield

63110

Vanda Investigational Site, St Louis

70526

Vanda Investigational Site, Crowley

77030

Vanda Investigational Site, Houston

78218

Vanda Investigational Site, San Antonio

78660

Vanda Investigational Site, Pflugerville

84088

Vanda Investigational Site, West Jordan

89119

Vanda Investigational Site, Las Vegas

90717

Vanda Investigational Site, Lomita

91436

Vanda Investigational Site, Encino

92024

Vanda Investigational Site, Encinitas

92122

Vanda Investigational Site, San Diego

92123

Vanda Investigational Site, San Diego

97239

Vanda Investigational Site, Portland

98101

Vanda Investigational Site, Seattle

99202

Vanda Investigational Site, Spokane

02919

Vanda Investigational Site, Johnston

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY